摘要
目的探索在临床患有食管癌患者的诊断中,将 D-二聚体与肿瘤标记物联合进行检测的具体价值.方泫选择本 院 2012年 7 月？201 6年 7 月收治的 8 0例食管癌患者作为实验对象,将所有患者随机均分作单一组与联合组,单一组患者 单纯接受肿瘤标记物检测,联合组患者在此基础上联合接受 D-二聚体检测,对比两组实验对象的阳性检出率.结果 联合组 患者的阳性检出率 87. 50%（35/40）明显高于单一组的阳性检出率 52. 50（21/40）, 差异存在统计学意义 （ P〈0 . 05） 结论 在临床食管癌患者诊断中,将 D -二聚体与肿瘤标记物联合用于临床检测的效果较好,值得推广.
Objective To explore the specific value of the combination of D-dimer and tumor marker in the clinical di-agnosis of patients with esophageal cancer. Methods 80 patients with esophageal cancer treated in our hospital from July 2012 to July 2016 were selected as the research subjects. All the patients were randomly divided into single group and combined group. Patients in the single group received tumor markers detection alone, while patients in the combined group additionally underwent the D-dimer detection besides the tumor marker detection, the positive detection rate was compared between the two groups. Results The positive rate in the combined group was 87. 50% （35/40） , which was significantly higher than 52. 50% （21/40） in the single group, the difference was statistically significant （P〈C〇 . 05）. Conclusion In the clinical diagno-sis of esophageal cancer patients？ the combined application of D -dimer and tumor markers in clinical detection demonstrated the good effect, it is worthy of promotion.
出处
《临床研究》
2017年第9期28-29,共2页
Clinical Research
